scholarly article | Q13442814 |
P2093 | author name string | Jing Xu | |
Xue-Guang Zhang | |||
Meng-Jiao Wang | |||
Pei-Rong Lu | |||
Gao-Qin Liu | |||
Hong-Ya Wu | |||
P2860 | cites work | Stabilizing the VE-cadherin-catenin complex blocks leukocyte extravasation and vascular permeability | Q24634777 |
Angiogenesis: an organizing principle for drug discovery? | Q29614538 | ||
Moesin1 and Ve-cadherin are required in endothelial cells during in vivo tubulogenesis | Q30496231 | ||
Vascular endothelial-cadherin stabilizes at cell-cell junctions by anchoring to circumferential actin bundles through alpha- and beta-catenins in cyclic AMP-Epac-Rap1 signal-activated endothelial cells | Q33647027 | ||
Protective and antioxidant effects of PPARα in the ischemic retina | Q33943655 | ||
Biomarkers of apoptosis: release of cytochrome c, activation of caspase-3, induction of 8-hydroxy-2'-deoxyguanosine, increased 3-nitrotyrosine, and alteration of p53 gene | Q34336162 | ||
Critical role of SDF-1α-induced progenitor cell recruitment and macrophage VEGF production in the experimental corneal neovascularization. | Q35166644 | ||
Inhibited experimental corneal neovascularization by neutralizing anti-SDF-1α antibody | Q35924203 | ||
Angiogenesis: the VE-cadherin switch | Q36394671 | ||
Vesicular trafficking of tyrosine kinase receptors and associated proteins in the regulation of signaling and vascular function | Q36436394 | ||
Ocular neovascularization: Implication of endogenous angiogenic inhibitors and potential therapy | Q36639215 | ||
The molecular basis of corneal transparency | Q37053777 | ||
Cell adhesion dynamics at endothelial junctions: VE-cadherin as a major player | Q37326058 | ||
Gallic acid, an active constituent of grape seed extract, exhibits anti-proliferative, pro-apoptotic and anti-tumorigenic effects against prostate carcinoma xenograft growth in nude mice | Q37340301 | ||
Emerging techniques to treat corneal neovascularisation | Q37943247 | ||
VE-cadherin and endothelial adherens junctions: active guardians of vascular integrity | Q38138649 | ||
Critical Role of IP-10 on Reducing Experimental Corneal Neovascularization | Q38948540 | ||
The cadherins: cell-cell adhesion molecules controlling animal morphogenesis | Q39525918 | ||
Angioregressive pretreatment of mature corneal blood vessels before keratoplasty: fine-needle vessel coagulation combined with anti-VEGFs | Q39648558 | ||
Selective targeting of angiogenic tumor vasculature by vascular endothelial-cadherin antibody inhibits tumor growth without affecting vascular permeability | Q43974009 | ||
Neovascularisation of the cornea | Q46666351 | ||
[Molecular mechanism of apoptosis] | Q74317477 | ||
Bevacizumab as a potent inhibitor of inflammatory corneal angiogenesis and lymphangiogenesis | Q80381830 | ||
[Mechanisms and regulation of corneal neovascularization] | Q85052449 | ||
P433 | issue | 6 | |
P921 | main subject | endothelium | Q111140 |
neovascularization | Q1281049 | ||
P304 | page(s) | 1083-1088 | |
P577 | publication date | 2015-12-18 | |
P1433 | published in | International Journal of Ophthalmology | Q26841911 |
P1476 | title | Anti-apoptosis effects of vascular endothelial cadherin in experimental corneal neovascularization | |
P478 | volume | 8 |
Q90207070 | Blockade of insulin receptor substrate-1 inhibits biological behavior of choroidal endothelial cells |
Q37393447 | VE-cadherin involved in the pulmonary microvascular endothelial cell barrier injury induced by angiotensin II through modulating the cellular apoptosis and skeletal rearrangement |
Search more.